A hospital has warned that some appointments could be cancelled because sleep study equipment has not been returned by ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

George: The phase 1/2 study is evaluating a new compound called DCC-3009. It is a drug that was designed specifically to work ...

Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8th at 8:00am ET to present updated data from the BEACON study in CSU and the open-label extension study ...

A new study from the University of Portsmouth's Research Group in Breast Health (RGBH), in collaboration with and funded by ...

Octapharma USA, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new 2-gram presentation ...

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...

In a 2025 study published titled ‘Human monogamy in mammalian context’, Dr Mark Dyble examined the mating behaviour of 35 ...

Children in Gaza return to learning through tent classrooms, as ceasefire enables limited schooling after prolonged conflict ...

A Derbyshire council is pursuing plans to reintroduce beavers, following success elsewhere in the county, in a bid to boost ...

Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock rose 4.9% in after-hours trading Wednesday following the announcement of key leadership changes as the company prepares to advance its lead ...

The U.S. Health Resources and Services Administration issued new recommendations on Monday that will eventually allow women ...